,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.1,Tongue disorder,6,16478569
1,22.1,Pleurisy,6,16478569
2,22.1,Angiosarcoma,6,16478569
3,22.1,Alopecia,6,16478569
4,22.1,Polymyositis,6,16478569
5,22.1,Abdominal discomfort,6,16478569
6,22.1,Gingival pain,6,16478569
7,22.1,Nausea,6,16478569
8,22.1,Urinary tract infection,6,16478569
9,22.1,Second primary malignancy,6,16478569
10,22.1,Cholecystitis,6,16478569
11,22.1,Pyrexia,6,16478569
12,22.1,Neoplasm progression,6,16478569
13,22.1,Diarrhoea,6,16478569
14,22.1,Fatigue,6,16478569
15,22.1,Stomatitis,6,16478569
16,22.1,Abdominal pain upper,6,16478569
17,22.1,Candida infection,6,16478569
0,22.0,Malaise,6,16478579
1,22.0,Gait disturbance,6,16478579
0,22.0,Malignant neoplasm progression,5,16478619
1,22.0,Off label use,1,16478619
0,22.0,Fatigue,6,16478669
0,22.1,Feeling abnormal,2,16478674
1,22.1,Taste disorder,6,16478674
2,22.1,Decreased appetite,6,16478674
0,22.0,Hyperkeratosis,3,16478675
1,22.0,Pain in extremity,3,16478675
0,22.1,Pyrexia,6,16478676
1,22.1,Full blood count decreased,6,16478676
2,22.1,Fatigue,1,16478676
3,22.1,Vomiting,1,16478676
4,22.1,Chills,6,16478676
5,22.1,Nausea,6,16478676
6,22.1,Diarrhoea,1,16478676
0,22.0,Neutropenia,6,16478699
0,22.0,Neutropenia,6,16478717
0,22.1,White blood cell count decreased,6,16478728
1,22.1,Dyspnoea,6,16478728
2,22.1,Pain in extremity,6,16478728
3,22.1,Colitis,6,16478728
0,22.1,Amnesia,3,16478740
0,22.0,Osteomyelitis,6,16478748
0,22.0,Nail disorder,6,16478749
1,22.0,Fatigue,6,16478749
2,22.0,Dry skin,6,16478749
3,22.0,Alopecia,6,16478749
4,22.0,Oedema peripheral,6,16478749
5,22.0,White blood cell count decreased,6,16478749
0,22.0,Fatigue,6,16478754
0,22.1,Diarrhoea,6,16478770
1,22.1,Fatigue,6,16478770
2,22.1,Gastrointestinal disorder,6,16478770
0,22.0,Neoplasm progression,3,16478772
0,22.0,Alopecia,3,16478777
1,22.0,Madarosis,3,16478777
2,22.0,Hair texture abnormal,3,16478777
3,22.0,Hair disorder,3,16478777
4,22.0,Hair colour changes,3,16478777
0,22.1,Neoplasm progression,6,16478778
0,22.0,Neoplasm progression,6,16478781
1,22.0,Abnormal loss of weight,6,16478781
2,22.0,Nausea,6,16478781
3,22.0,Neutropenia,6,16478781
4,22.0,Fatigue,6,16478781
0,22.1,Hair colour changes,3,16478787
1,22.1,Hair disorder,3,16478787
2,22.1,Alopecia,3,16478787
3,22.1,Hair texture abnormal,3,16478787
0,22.0,Tumour invasion,6,16478788
1,22.0,Sarcoma uterus,6,16478788
0,22.0,Product use in unapproved indication,6,16478798
1,22.0,Rash generalised,3,16478798
0,22.0,Sarcoma uterus,6,16478802
1,22.0,Tumour invasion,6,16478802
0,22.1,Hair disorder,3,16478826
1,22.1,Hair texture abnormal,3,16478826
2,22.1,Madarosis,3,16478826
3,22.1,Hair colour changes,3,16478826
4,22.1,Alopecia,3,16478826
5,22.1,Depression,6,16478826
0,22.1,Fatigue,2,16478828
0,22.0,Malignant neoplasm progression,3,16478851
1,22.0,Ascites,3,16478851
2,22.0,Platelet count decreased,6,16478851
0,22.1,Hepatic function abnormal,2,16478865
1,22.1,Neuropathy peripheral,3,16478865
2,22.1,White blood cell count decreased,1,16478865
3,22.1,Alanine aminotransferase increased,2,16478865
4,22.1,Aspartate aminotransferase increased,2,16478865
5,22.1,Platelet count decreased,1,16478865
6,22.1,Haemoglobin decreased,2,16478865
7,22.1,Febrile neutropenia,1,16478865
8,22.1,Pyrexia,1,16478865
0,22.0,Tumour invasion,6,16478870
1,22.0,Sarcoma uterus,6,16478870
0,22.0,Neoplasm progression,6,16478905
0,22.0,Interstitial lung disease,2,16478953
1,22.0,Pulmonary toxicity,2,16478953
0,22.0,Death,5,16478959
1,22.0,Nasopharyngitis,6,16478959
0,22.0,Paronychia,2,16479021
1,22.0,Malignant neoplasm progression,6,16479021
0,22.1,Cardiac failure chronic,6,16479039
1,22.1,Congestive cardiomyopathy,6,16479039
0,22.0,Neutropenia,1,16479048
1,22.0,Febrile neutropenia,1,16479048
2,22.0,Anaemia,1,16479048
3,22.0,Thrombocytopenia,1,16479048
0,22.0,Malignant neoplasm progression,5,16479313
0,22.0,Bone marrow toxicity,2,16479349
1,22.0,Anaemia,2,16479349
0,22.0,Aspartate aminotransferase increased,2,16479389
1,22.0,Alanine aminotransferase increased,2,16479389
2,22.0,Product substitution issue,6,16479389
0,22.0,Cough,1,16479398
1,22.0,Laryngospasm,1,16479398
0,22.1,Anaemia,2,16479405
1,22.1,Ileus,1,16479405
0,22.0,Cerebrovascular accident,6,16479410
0,22.0,Death,5,16479436
1,22.0,Disease progression,6,16479436
2,22.0,Underdose,6,16479436
3,22.0,Abdominal discomfort,6,16479436
4,22.0,Oropharyngeal pain,6,16479436
0,22.0,Product supply issue,6,16479472
1,22.0,Product availability issue,6,16479472
2,22.0,Bladder cancer recurrent,6,16479472
0,22.0,Atrial fibrillation,3,16479516
1,22.0,Myocarditis,3,16479516
2,22.0,Muscular weakness,1,16479516
0,22.0,Metastases to central nervous system,6,16479574
1,22.0,Bacterial sepsis,6,16479574
0,22.0,Therapeutic product effect decreased,6,16479591
1,22.0,Prostate cancer metastatic,6,16479591
0,22.0,Prostate cancer metastatic,5,16479615
1,22.0,Myocardial infarction,5,16479615
0,22.0,Febrile neutropenia,5,16479647
0,22.0,Musculoskeletal pain,1,16479659
0,22.0,Back pain,2,16479675
1,22.0,Suffocation feeling,2,16479675
0,22.1,Dehydration,1,16479692
1,22.1,Nausea,3,16479692
2,22.1,Skin fragility,3,16479692
3,22.1,Hyperkalaemia,1,16479692
4,22.1,Diarrhoea,3,16479692
5,22.1,Sleep disorder,3,16479692
6,22.1,Depression,3,16479692
7,22.1,Renal failure,1,16479692
8,22.1,Renal failure,3,16479692
9,22.1,Cognitive disorder,3,16479692
10,22.1,Pain,3,16479692
11,22.1,Metastases to liver,5,16479692
12,22.1,Epistaxis,1,16479692
13,22.1,Fall,1,16479692
14,22.1,Visual acuity reduced,3,16479692
15,22.1,Urinary tract disorder,3,16479692
16,22.1,Facial bones fracture,1,16479692
17,22.1,Fatigue,3,16479692
18,22.1,Tremor,3,16479692
0,22.0,Malaise,3,16479693
1,22.0,Proteinuria,3,16479693
0,22.0,Mouth ulceration,6,16479701
1,22.0,Lupus-like syndrome,1,16479701
0,22.1,Product use in unapproved indication,6,16479708
1,22.1,Dry mouth,1,16479708
2,22.1,Blood sodium decreased,3,16479708
3,22.1,Abdominal discomfort,6,16479708
4,22.1,Blood pressure increased,1,16479708
5,22.1,Underdose,6,16479708
6,22.1,Product dose omission,6,16479708
7,22.1,Thrombosis,1,16479708
8,22.1,Joint swelling,1,16479708
9,22.1,Diarrhoea,2,16479708
10,22.1,Insomnia,3,16479708
11,22.1,Constipation,2,16479708
12,22.1,Red blood cell count decreased,3,16479708
13,22.1,Nausea,6,16479708
14,22.1,Haematocrit decreased,6,16479708
15,22.1,Product size issue,6,16479708
16,22.1,Glossodynia,1,16479708
17,22.1,Taste disorder,3,16479708
18,22.1,Decreased appetite,2,16479708
19,22.1,Weight decreased,3,16479708
20,22.1,Blood creatinine increased,6,16479708
21,22.1,Retching,1,16479708
22,22.1,Carbohydrate antigen 125 increased,2,16479708
23,22.1,Haemoglobin decreased,6,16479708
0,22.0,Nausea,1,16479756
1,22.0,General physical health deterioration,1,16479756
2,22.0,General physical health deterioration,1,16479756
3,22.0,Leukopenia,1,16479756
0,22.1,Neutropenic sepsis,1,16479786
1,22.1,Autoimmune hepatitis,1,16479786
0,22.0,Headache,1,16479825
0,22.0,Malignant neoplasm progression,5,16479826
0,22.1,Prescribed overdose,2,16479835
1,22.1,Rhythm idioventricular,2,16479835
2,22.1,Product prescribing error,2,16479835
3,22.1,Acute kidney injury,2,16479835
4,22.1,Hyperkalaemia,2,16479835
5,22.1,Sinus arrest,2,16479835
0,22.0,Anaemia,6,16479878
1,22.0,Pulmonary embolism,6,16479878
2,22.0,Venous thrombosis limb,6,16479878
0,22.0,Dyspnoea,1,16479892
1,22.0,Back pain,1,16479892
2,22.0,Palpitations,1,16479892
0,22.0,Hot flush,1,16479893
1,22.0,Palpitations,1,16479893
2,22.0,Chest discomfort,1,16479893
0,22.0,Febrile neutropenia,5,16479895
0,22.0,Decreased appetite,6,16479914
0,22.0,Dysphonia,1,16479953
1,22.0,Blood pressure increased,1,16479953
2,22.0,Wheezing,1,16479953
0,22.1,Device related infection,1,16480006
1,22.1,Blood creatine increased,1,16480006
2,22.1,Pulmonary arterial hypertension,1,16480006
3,22.1,Transfusion,1,16480006
4,22.1,Staphylococcus test positive,1,16480006
5,22.1,Lung infiltration,6,16480006
6,22.1,Dehydration,6,16480006
7,22.1,Asthenia,1,16480006
8,22.1,Septic pulmonary embolism,6,16480006
9,22.1,Cor pulmonale,6,16480006
10,22.1,Hyperkalaemia,1,16480006
11,22.1,Metabolic acidosis,1,16480006
12,22.1,Catheter management,6,16480006
13,22.1,Oedema peripheral,6,16480006
14,22.1,Hyponatraemia,6,16480006
15,22.1,Arthralgia,6,16480006
16,22.1,Back pain,1,16480006
17,22.1,Pulmonary hypertension,6,16480006
18,22.1,Pain in extremity,6,16480006
19,22.1,Catheter site rash,6,16480006
20,22.1,Oxygen saturation decreased,1,16480006
21,22.1,Haematocrit decreased,1,16480006
22,22.1,Staphylococcal sepsis,1,16480006
23,22.1,Condition aggravated,1,16480006
24,22.1,Fall,1,16480006
25,22.1,Vomiting,1,16480006
26,22.1,Platelet count decreased,1,16480006
27,22.1,Somnolence,6,16480006
28,22.1,Pleural effusion,6,16480006
29,22.1,Metastases to bone,6,16480006
30,22.1,Syncope,1,16480006
31,22.1,Hypotension,1,16480006
32,22.1,Haemoglobin decreased,1,16480006
33,22.1,Myocardial ischaemia,1,16480006
34,22.1,Troponin increased,1,16480006
35,22.1,Acute kidney injury,1,16480006
36,22.1,Fatigue,6,16480006
37,22.1,Dyspnoea,1,16480006
38,22.1,Pulmonary embolism,6,16480006
39,22.1,White blood cell count decreased,1,16480006
40,22.1,Pneumonia,6,16480006
41,22.1,Hypoxia,6,16480006
42,22.1,Oedema,6,16480006
43,22.1,Thrombocytopenia,1,16480006
44,22.1,Red blood cell count decreased,1,16480006
45,22.1,Nausea,1,16480006
46,22.1,Chest pain,6,16480006
47,22.1,Cancer pain,6,16480006
48,22.1,Right ventricular failure,6,16480006
49,22.1,Anaemia,6,16480006
50,22.1,Acute respiratory failure,1,16480006
51,22.1,Metastases to central nervous system,6,16480006
52,22.1,Weight increased,6,16480006
0,22.0,Femoral neck fracture,6,16480161
0,22.0,Radiation pneumonitis,2,16480179
0,22.1,Malaise,6,16480180
1,22.1,Malignant neoplasm progression,3,16480180
2,22.1,Anaemia,6,16480180
3,22.1,Type 2 diabetes mellitus,3,16480180
4,22.1,Diarrhoea,3,16480180
5,22.1,Pain,3,16480180
6,22.1,Fatigue,3,16480180
7,22.1,Irritability,3,16480180
8,22.1,Abnormal faeces,1,16480180
9,22.1,Pain in extremity,3,16480180
10,22.1,Rash,3,16480180
11,22.1,Radiation associated pain,3,16480180
12,22.1,Nausea,3,16480180
13,22.1,Abdominal pain upper,3,16480180
14,22.1,Neuropathy peripheral,3,16480180
15,22.1,Cough,3,16480180
16,22.1,Therapy partial responder,6,16480180
17,22.1,Faeces discoloured,1,16480180
18,22.1,Adverse drug reaction,3,16480180
19,22.1,Product dose omission,6,16480180
20,22.1,Underdose,6,16480180
0,22.0,Death,5,16480190
1,22.0,Breast cancer metastatic,6,16480190
0,22.0,Second primary malignancy,6,16480218
1,22.0,Pancreatic carcinoma,6,16480218
0,22.0,Carcinoembryonic antigen increased,6,16480221
1,22.0,Blood albumin increased,2,16480221
2,22.0,Neoplasm progression,6,16480221
0,22.0,Nausea,1,16480222
1,22.0,Dizziness,1,16480222
0,22.0,Feeding disorder,1,16480225
1,22.0,Fall,1,16480225
2,22.0,Asthenia,1,16480225
3,22.0,Dehydration,1,16480225
4,22.0,Decreased appetite,1,16480225
5,22.0,White blood cell count decreased,1,16480225
6,22.0,Wound haemorrhage,1,16480225
7,22.0,Oesophageal pain,1,16480225
8,22.0,Gastrooesophageal reflux disease,1,16480225
9,22.0,Gait disturbance,1,16480225
10,22.0,Head injury,1,16480225
11,22.0,Nasopharyngitis,1,16480225
12,22.0,Abdominal discomfort,1,16480225
13,22.0,Red blood cell count decreased,1,16480225
14,22.0,Immune system disorder,1,16480225
15,22.0,Malaise,1,16480225
16,22.0,Wound dehiscence,1,16480225
0,22.0,Pancytopenia,1,16480238
1,22.0,Splenomegaly,6,16480238
2,22.0,Visceral leishmaniasis,1,16480238
3,22.0,Lymphadenopathy,6,16480238
4,22.0,Chordae tendinae rupture,6,16480238
5,22.0,Hepatomegaly,6,16480238
6,22.0,Hypoalbuminaemia,6,16480238
7,22.0,Pyrexia,6,16480238
8,22.0,Hypergammaglobulinaemia,6,16480238
0,22.0,Enterocolitis,1,16480273
0,22.0,Hypersensitivity pneumonitis,1,16480276
0,22.1,Myositis,6,16480278
1,22.1,Vocal cord dysfunction,1,16480278
2,22.1,Muscular weakness,6,16480278
3,22.1,Blood creatine phosphokinase increased,2,16480278
0,22.0,Death,5,16480282
0,22.0,Haemoglobin decreased,6,16480283
0,22.0,Metastases to central nervous system,6,16480286
1,22.0,Neurological procedural complication,5,16480286
0,22.0,Erythema,6,16480287
1,22.0,Drug resistance,6,16480287
2,22.0,Vomiting,6,16480287
3,22.0,Malignant neoplasm progression,5,16480287
0,22.0,Drug resistance,6,16480290
1,22.0,Malignant neoplasm progression,6,16480290
0,22.0,Skin disorder,6,16480299
0,22.0,Lung disorder,6,16480302
1,22.0,Mental disorder,6,16480302
2,22.0,White blood cell count decreased,6,16480302
0,22.1,Therapeutic response unexpected,6,16480314
1,22.1,Arthropathy,6,16480314
2,22.1,Product dose omission,6,16480314
3,22.1,Pre-existing condition improved,6,16480314
4,22.1,Eating disorder,1,16480314
5,22.1,White blood cell count decreased,1,16480314
6,22.1,Sinusitis bacterial,1,16480314
0,22.1,White blood cell count decreased,1,16480324
1,22.1,Nausea,1,16480324
0,22.1,Pneumonia,6,16480325
1,22.1,Headache,1,16480325
2,22.1,Feeling abnormal,6,16480325
3,22.1,Diarrhoea,1,16480325
4,22.1,Dysgeusia,6,16480325
0,22.0,Fatigue,1,16480327
1,22.0,Fatigue,6,16480327
2,22.0,Abdominal discomfort,1,16480327
3,22.0,Retching,1,16480327
4,22.0,Nausea,1,16480327
0,22.0,Alopecia,3,16480328
1,22.0,Madarosis,3,16480328
0,22.0,Alopecia,3,16480329
1,22.0,Hair texture abnormal,6,16480329
2,22.0,Hair disorder,6,16480329
3,22.0,Hair colour changes,6,16480329
4,22.0,Madarosis,3,16480329
0,22.0,Madarosis,3,16480330
1,22.0,Alopecia,3,16480330
0,22.1,Alopecia,3,16480331
1,22.1,Hair texture abnormal,3,16480331
2,22.1,Madarosis,3,16480331
3,22.1,Hair colour changes,3,16480331
4,22.1,Hair disorder,3,16480331
0,22.0,Death,5,16480346
0,22.0,Death,5,16480349
0,22.0,Death,5,16480350
0,22.0,Death,5,16480353
0,22.0,Death,5,16480354
0,22.0,Death,5,16480357
0,22.0,Death,5,16480359
0,22.0,Nausea,3,16480365
0,22.0,Haemorrhage,6,16480371
0,22.0,Urinary tract obstruction,6,16480409
0,22.0,Stomatitis,6,16480420
0,22.0,Alopecia,6,16480424
1,22.0,Viral infection,6,16480424
2,22.0,Constipation,6,16480424
3,22.0,Dry skin,6,16480424
4,22.0,Insomnia,6,16480424
5,22.0,Weight decreased,6,16480424
6,22.0,Taste disorder,6,16480424
7,22.0,Diarrhoea,6,16480424
8,22.0,Malaise,6,16480424
9,22.0,Headache,6,16480424
10,22.0,Nausea,6,16480424
11,22.0,Cough,6,16480424
12,22.0,Dry mouth,6,16480424
13,22.0,Respiratory tract congestion,6,16480424
14,22.0,Pyrexia,6,16480424
0,22.0,Nephrolithiasis,6,16480431
1,22.0,Kidney infection,6,16480431
2,22.0,Vomiting,6,16480431
3,22.0,Product use in unapproved indication,6,16480431
0,22.0,Second primary malignancy,6,16480448
0,22.0,Fatigue,1,16480450
1,22.0,Fall,6,16480450
2,22.0,Muscular weakness,1,16480450
3,22.0,Dyspnoea,1,16480450
4,22.0,Brain natriuretic peptide increased,1,16480450
5,22.0,Upper gastrointestinal haemorrhage,1,16480450
0,22.1,Drug ineffective,6,16480451
0,22.0,Pancytopenia,6,16480500
1,22.0,Cerebrovascular accident,4,16480500
0,22.0,Trousseau^s syndrome,6,16480506
0,22.0,Pulmonary embolism,3,16480509
0,22.0,Computerised tomogram thorax abnormal,6,16480511
1,22.0,Chest X-ray abnormal,6,16480511
2,22.0,Hypoxia,6,16480511
3,22.0,Pulmonary mass,6,16480511
0,22.0,Immune thrombocytopenic purpura,1,16480516
0,22.0,Death,5,16480523
0,22.0,Diarrhoea,6,16480540
1,22.0,Fatigue,6,16480540
2,22.0,Fatigue,6,16480540
3,22.0,Myalgia,6,16480540
4,22.0,Flatulence,1,16480540
5,22.0,Flatulence,6,16480540
6,22.0,Diarrhoea,1,16480540
7,22.0,Myalgia,6,16480540
0,22.0,Thrombosis,6,16480544
0,22.0,Breast cancer,6,16480587
1,22.0,Death,5,16480587
2,22.0,Malignant neoplasm progression,6,16480587
0,22.0,Fatigue,6,16480596
0,22.0,Intestinal ischaemia,1,16480614
1,22.0,Bone marrow failure,1,16480614
0,22.0,Product use in unapproved indication,6,16480706
1,22.0,Ill-defined disorder,1,16480706
0,22.0,Product use in unapproved indication,6,16481033
1,22.0,Fatigue,6,16481033
0,22.0,Product supply issue,6,16481256
1,22.0,Product availability issue,6,16481256
2,22.0,Anxiety,6,16481256
3,22.0,Blood pressure increased,6,16481256
0,22.0,Bronchitis,6,16481300
1,22.0,Cubital tunnel syndrome,6,16481300
2,22.0,Nerve compression,2,16481300
3,22.0,Motor dysfunction,2,16481300
4,22.0,Carpal tunnel syndrome,3,16481300
5,22.0,Sensory loss,2,16481300
6,22.0,Mobility decreased,3,16481300
0,22.0,Malignant neoplasm progression,6,16481333
0,22.1,Liver function test increased,1,16481334
1,22.1,Aspartate aminotransferase increased,6,16481334
2,22.1,Hepatic necrosis,1,16481334
3,22.1,Dyspnoea,1,16481334
4,22.1,Blood creatinine increased,1,16481334
5,22.1,Hepatic failure,1,16481334
6,22.1,Alanine aminotransferase increased,6,16481334
0,22.0,Dyspnoea,3,16481350
1,22.0,Prostatic specific antigen increased,1,16481350
2,22.0,Fatigue,3,16481350
3,22.0,Cardiac disorder,3,16481350
0,22.0,Cartilage atrophy,3,16481361
1,22.0,Arthralgia,3,16481361
2,22.0,Osteoarthritis,3,16481361
0,22.1,Malaise,6,16481460
1,22.1,Pulmonary embolism,1,16481460
2,22.1,Retinal artery occlusion,4,16481460
3,22.1,Deep vein thrombosis,1,16481460
4,22.1,Thrombosis,6,16481460
5,22.1,Cerebral infarction,3,16481460
6,22.1,Malignant neoplasm progression,5,16481460
0,22.0,Cardio-respiratory arrest,6,16481519
0,22.0,Secretory adenoma of pituitary,1,16481521
0,22.0,Prostate cancer metastatic,6,16481527
0,22.0,Perforation,1,16481529
0,22.0,Tumour invasion,6,16481537
1,22.0,Metastases to lymph nodes,6,16481537
2,22.0,Sarcoma uterus,6,16481537
0,22.0,Duodenal ulcer,3,16481542
0,22.0,Metastases to lung,6,16481595
0,22.0,Drug eruption,6,16481643
1,22.0,Seizure,6,16481643
2,22.0,Disease progression,6,16481643
3,22.0,Mental status changes,6,16481643
4,22.0,Vomiting,6,16481643
5,22.0,Posterior reversible encephalopathy syndrome,6,16481643
0,22.1,Neuropathy peripheral,6,16481648
1,22.1,Palmar-plantar erythrodysaesthesia syndrome,6,16481648
2,22.1,Pneumocystis jirovecii pneumonia,2,16481648
3,22.1,Thrombocytopenia,6,16481648
4,22.1,Tumour perforation,6,16481648
0,22.0,Nausea,1,16481666
1,22.0,Fatigue,1,16481666
2,22.0,Diarrhoea,1,16481666
3,22.0,White blood cell count decreased,1,16481666
4,22.0,Decreased appetite,1,16481666
0,22.0,Bone marrow failure,2,16481700
0,22.0,Chylothorax,1,16481718
1,22.0,Product use in unapproved indication,6,16481718
2,22.0,Off label use,6,16481718
0,22.0,Tooth loss,6,16481782
1,22.0,Oral infection,6,16481782
2,22.0,Toothache,6,16481782
3,22.0,Osteonecrosis of jaw,3,16481782
0,22.0,Vomiting,1,16481807
1,22.0,Nausea,1,16481807
2,22.0,Product quality issue,6,16481807
3,22.0,Muscle spasms,1,16481807
4,22.0,Infusion related reaction,1,16481807
5,22.0,Hyperhidrosis,1,16481807
0,22.0,Cerebral haemorrhage,5,16481814
0,22.0,Hyperthyroidism,6,16481877
1,22.0,Autoimmune thyroiditis,6,16481877
0,22.0,Death,5,16481893
0,22.0,Papilloedema,6,16481898
1,22.0,Optic neuritis,6,16481898
0,22.0,Death,5,16481899
0,22.0,Bone lesion,6,16481920
1,22.0,Pathological fracture,6,16481920
2,22.0,Femur fracture,6,16481920
0,22.0,Brain oedema,6,16481925
0,22.0,Febrile neutropenia,2,16481950
0,22.0,Alopecia,3,16482006
1,22.0,Psychological trauma,6,16482006
0,22.0,Psychological trauma,6,16482007
1,22.0,Alopecia,2,16482007
0,22.0,Alopecia,2,16482014
1,22.0,Psychological trauma,6,16482014
0,22.0,Alopecia,2,16482015
1,22.0,Psychological trauma,6,16482015
0,22.0,Second primary malignancy,6,16482050
0,22.0,Alopecia,2,16482059
1,22.0,Psychological trauma,6,16482059
0,22.0,Alopecia,2,16482060
1,22.0,Psychological trauma,6,16482060
0,22.0,Psychological trauma,6,16482076
1,22.0,Alopecia,2,16482076
0,22.0,Psychological trauma,6,16482102
1,22.0,Alopecia,2,16482102
0,22.0,Death,5,16482172
0,22.0,Fall,2,16482192
0,22.0,Chemotherapy,6,16482218
0,22.1,Poor quality product administered,6,16482223
1,22.1,Tumour marker increased,6,16482223
2,22.1,Muscle spasms,6,16482223
3,22.1,Mental impairment,6,16482223
4,22.1,Pain,6,16482223
5,22.1,Pyloric stenosis,6,16482223
6,22.1,Product storage error,6,16482223
7,22.1,Constipation,6,16482223
8,22.1,Fatigue,6,16482223
9,22.1,Neoplasm progression,6,16482223
10,22.1,Asthenia,6,16482223
11,22.1,Diarrhoea,6,16482223
0,22.1,Increased tendency to bruise,1,16482231
1,22.1,Prostate cancer metastatic,4,16482231
2,22.1,Product use issue,1,16482231
0,22.0,Disease progression,6,16482250
1,22.0,Dermatitis acneiform,6,16482250
2,22.0,Colon cancer,6,16482250
3,22.0,Hypersensitivity,6,16482250
0,22.0,Epilepsy,6,16482259
1,22.0,Metastases to central nervous system,6,16482259
2,22.0,Platelet count decreased,2,16482259
0,22.0,Muscle rigidity,2,16482288
1,22.0,Pain,2,16482288
0,22.0,Transaminases increased,2,16482303
0,22.0,Extravasation,2,16482304
0,22.0,Tinnitus,2,16482309
1,22.0,Neutropenia,2,16482309
2,22.0,Anaemia,2,16482309
3,22.0,Nausea,1,16482309
4,22.0,Vomiting,1,16482309
0,22.0,Neutropenia,6,16482321
1,22.0,Leukopenia,6,16482321
0,22.1,Pemphigoid,1,16482326
0,22.0,Hypertension,2,16482348
1,22.0,Proteinuria,1,16482348
0,22.0,Hyperammonaemia,2,16482350
1,22.0,Circulatory collapse,6,16482350
2,22.0,Renal impairment,6,16482350
3,22.0,Metabolic acidosis,6,16482350
4,22.0,Pneumonia aspiration,6,16482350
5,22.0,Diarrhoea,6,16482350
0,22.0,Rash,3,16482500
0,22.0,Tooth loss,6,16482513
1,22.0,Toothache,6,16482513
2,22.0,Oral infection,6,16482513
3,22.0,Osteonecrosis of jaw,3,16482513
0,22.1,Ileus,1,16482515
0,22.0,Death,5,16482522
0,22.0,Venous thrombosis,6,16482523
0,22.0,Death,5,16482571
1,22.0,Malaise,6,16482571
0,22.0,Death,5,16482586
0,22.0,Death,5,16482599
0,22.0,Anger,3,16482601
1,22.0,Loss of libido,6,16482601
2,22.0,Menopausal symptoms,3,16482601
3,22.0,Lacrimation increased,3,16482601
4,22.0,Anxiety,3,16482601
0,22.0,Pneumocystis jirovecii pneumonia,6,16482632
1,22.0,Pulmonary embolism,6,16482632
2,22.0,Pneumonitis,1,16482632
0,22.0,Jaundice,6,16482662
1,22.0,Off label use,6,16482662
2,22.0,Abdominal pain,2,16482662
3,22.0,Transaminases increased,6,16482662
4,22.0,Pruritus,2,16482662
5,22.0,Chromaturia,6,16482662
0,22.0,Tuberculosis,6,16482663
0,22.0,Hypersensitivity,1,16482668
1,22.0,Hypotension,2,16482668
2,22.0,Tremor,1,16482668
3,22.0,Hyperthermia,2,16482668
0,22.0,Neutropenia,5,16482676
1,22.0,Pyrexia,5,16482676
2,22.0,Vomiting,5,16482676
3,22.0,Leukopenia,5,16482676
4,22.0,Thrombocytopenia,5,16482676
5,22.0,Nausea,5,16482676
6,22.0,Mucosal inflammation,5,16482676
7,22.0,Diarrhoea,5,16482676
0,22.1,Decreased appetite,1,16482683
1,22.1,Therapy non-responder,6,16482683
2,22.1,Colitis,1,16482683
3,22.1,Speech disorder,2,16482683
4,22.1,Asthenia,2,16482683
5,22.1,Haematochezia,1,16482683
6,22.1,Productive cough,2,16482683
7,22.1,Product use in unapproved indication,6,16482683
8,22.1,Abdominal pain upper,1,16482683
9,22.1,Abdominal pain,3,16482683
10,22.1,Movement disorder,6,16482683
11,22.1,Vomiting,1,16482683
12,22.1,Fracture pain,2,16482683
13,22.1,Vision blurred,6,16482683
14,22.1,Urinary retention,1,16482683
15,22.1,Dysgeusia,1,16482683
16,22.1,Femur fracture,6,16482683
17,22.1,Gastritis,6,16482683
18,22.1,Nasopharyngitis,2,16482683
19,22.1,Headache,6,16482683
20,22.1,Enuresis,6,16482683
21,22.1,Rash,3,16482683
22,22.1,Fatigue,2,16482683
23,22.1,Diarrhoea,1,16482683
24,22.1,Duodenogastric reflux,2,16482683
25,22.1,Cerebrovascular accident,6,16482683
26,22.1,Duodenitis,1,16482683
27,22.1,Rhinorrhoea,2,16482683
0,22.0,Platelet count decreased,2,16482686
1,22.0,Hypertension,2,16482686
2,22.0,Malaise,2,16482686
0,22.0,Death,5,16482710
0,22.0,Bronchospasm,1,16482739
0,22.0,Therapy partial responder,6,16482761
1,22.0,Leukopenia,6,16482761
0,22.0,Cellulitis,1,16482766
0,22.0,Extravasation,2,16482769
0,22.0,Diarrhoea,1,16482770
1,22.0,Asthenia,1,16482770
2,22.0,Nausea,1,16482770
3,22.0,Seizure,1,16482770
4,22.0,Pyrexia,1,16482770
0,22.0,Extravasation,2,16482771
0,22.0,Insomnia,6,16482779
1,22.0,Decreased appetite,6,16482779
2,22.0,Memory impairment,1,16482779
3,22.0,Drug hypersensitivity,6,16482779
4,22.0,Delirium,6,16482779
5,22.0,Mental status changes,6,16482779
6,22.0,Confusional state,1,16482779
0,22.0,Death,5,16482781
0,22.0,Death,5,16482783
0,22.0,Death,5,16482784
0,22.0,Death,5,16482786
0,22.0,Cerebrovascular accident,6,16482788
1,22.0,Injection site cellulitis,1,16482788
0,22.0,Haemoglobin decreased,6,16482789
0,22.0,Neutropenic sepsis,5,16482791
1,22.0,Enterocolitis bacterial,5,16482791
2,22.0,Acute kidney injury,5,16482791
0,22.0,Death,5,16482800
0,22.1,Radiation pneumonitis,6,16482823
0,22.0,Acute myeloid leukaemia,3,16482832
1,22.0,Off label use,6,16482832
0,22.0,Cholecystitis acute,1,16482870
0,22.0,Renal failure,6,16482878
0,22.0,Pyrexia,1,16482933
0,22.0,Recurrent cancer,6,16482944
1,22.0,Anaemia,6,16482944
0,22.1,Thrombocytopenia,1,16482962
1,22.1,Venoocclusive liver disease,6,16482962
0,22.0,Death,5,16483003
0,22.1,Hepatic function abnormal,6,16483038
1,22.1,Cardiac failure congestive,2,16483038
2,22.1,Long QT syndrome,2,16483038
3,22.1,Dyspnoea,2,16483038
4,22.1,Decreased appetite,1,16483038
5,22.1,Dehydration,1,16483038
6,22.1,Product use issue,6,16483038
7,22.1,Stress cardiomyopathy,1,16483038
0,22.0,Lung disorder,6,16483040
1,22.0,Interstitial lung disease,1,16483040
2,22.0,Rash,6,16483040
0,22.0,Eye movement disorder,1,16483159
1,22.0,Flushing,1,16483159
2,22.0,Cold sweat,1,16483159
3,22.0,Chills,1,16483159
4,22.0,Back pain,1,16483159
5,22.0,Hypersensitivity,1,16483159
0,22.0,Pain,3,16483176
0,22.0,Death,5,16483196
1,22.0,Seizure,6,16483196
2,22.0,Loss of consciousness,3,16483196
0,22.0,Haemorrhage,3,16483207
1,22.0,Thrombocytopenia,3,16483207
0,22.0,Neoplasm progression,5,16483211
1,22.0,Haemoglobin decreased,6,16483211
2,22.0,Bone marrow failure,6,16483211
3,22.0,Blood iron decreased,6,16483211
0,22.0,Haematocrit decreased,6,16483212
1,22.0,White blood cell count decreased,1,16483212
2,22.0,Mouth ulceration,1,16483212
3,22.0,Haemoglobin decreased,6,16483212
4,22.0,Blood urea increased,6,16483212
5,22.0,Platelet count decreased,6,16483212
6,22.0,Malnutrition,1,16483212
7,22.0,Platelet count increased,6,16483212
0,22.0,Metabolic acidosis,1,16483226
1,22.0,Drug interaction,1,16483226
2,22.0,Acute kidney injury,1,16483226
3,22.0,Cardio-respiratory arrest,1,16483226
4,22.0,Hyperkalaemia,1,16483226
0,22.0,Death,5,16483239
0,22.1,Vitamin D deficiency,6,16483250
1,22.1,Type 2 diabetes mellitus,6,16483250
2,22.1,Hypercholesterolaemia,6,16483250
3,22.1,Chronic kidney disease,6,16483250
4,22.1,Neoplasm progression,6,16483250
5,22.1,Hand-foot-and-mouth disease,6,16483250
0,22.0,Death,5,16483254
0,22.0,Jaundice,6,16483260
1,22.0,Perforation,5,16483260
0,22.0,Stomal hernia,3,16483269
1,22.0,Headache,3,16483269
2,22.0,Chest pain,1,16483269
3,22.0,Mucosal inflammation,1,16483269
4,22.0,Dry skin,1,16483269
5,22.0,Oropharyngeal pain,1,16483269
6,22.0,Epistaxis,3,16483269
7,22.0,Stoma site haemorrhage,1,16483269
8,22.0,Nasal congestion,1,16483269
9,22.0,Anaemia,3,16483269
10,22.0,Dysphonia,3,16483269
11,22.0,Nasopharyngitis,1,16483269
12,22.0,Skin fissures,1,16483269
13,22.0,Cough,1,16483269
14,22.0,Oral herpes,1,16483269
15,22.0,Pyrexia,1,16483269
16,22.0,Abdominal pain,1,16483269
17,22.0,Viral infection,1,16483269
18,22.0,Neutropenia,1,16483269
19,22.0,Stoma site pain,3,16483269
20,22.0,Palmar-plantar erythrodysaesthesia syndrome,3,16483269
21,22.0,Dysuria,1,16483269
22,22.0,Blood iron decreased,1,16483269
23,22.0,Polyneuropathy,1,16483269
24,22.0,Lung infection,1,16483269
25,22.0,Stoma complication,1,16483269
0,22.0,Death,5,16483301
0,22.0,Neoplasm progression,5,16483306
0,22.0,Lymphadenopathy,3,16483333
1,22.0,Musculoskeletal chest pain,6,16483333
2,22.0,Pain in extremity,6,16483333
3,22.0,Product odour abnormal,6,16483333
4,22.0,Peripheral swelling,3,16483333
5,22.0,Fatigue,6,16483333
6,22.0,Hypoaesthesia,2,16483333
7,22.0,Thrombosis,6,16483333
8,22.0,Decreased activity,6,16483333
9,22.0,Arthralgia,6,16483333
0,22.0,Refractory cytopenia with unilineage dysplasia,6,16483334
0,22.1,Intestinal obstruction,6,16483359
1,22.1,Neoplasm progression,6,16483359
0,22.1,Nausea,1,16483361
1,22.1,Dysuria,1,16483361
2,22.1,Diarrhoea,1,16483361
3,22.1,Abdominal pain upper,1,16483361
4,22.1,Rhinorrhoea,1,16483361
5,22.1,Asthenia,1,16483361
6,22.1,Vomiting,1,16483361
7,22.1,Neuropathy peripheral,3,16483361
8,22.1,Vulvovaginal inflammation,1,16483361
0,22.0,Skin disorder,3,16483384
1,22.0,Aortic valve stenosis,3,16483384
2,22.0,Skin reaction,3,16483384
3,22.0,Impaired healing,3,16483384
0,22.0,Glycosylated haemoglobin increased,2,16483385
1,22.0,Blood glucose increased,2,16483385
0,22.1,Prostate cancer,5,16483386
0,22.0,Therapeutic product effect increased,6,16483419
1,22.0,Medication error,6,16483419
2,22.0,Logorrhoea,1,16483419
3,22.0,Euphoric mood,1,16483419
0,22.0,Cardiotoxicity,6,16483475
0,22.0,Weight decreased,6,16483494
1,22.0,Product use complaint,6,16483494
2,22.0,Rash,6,16483494
3,22.0,Nausea,6,16483494
4,22.0,Fatigue,6,16483494
5,22.0,Diarrhoea,6,16483494
6,22.0,Neuropathy peripheral,6,16483494
7,22.0,Eating disorder,6,16483494
8,22.0,Product use in unapproved indication,6,16483494
0,22.0,Pain in extremity,6,16483523
1,22.0,Arthralgia,6,16483523
2,22.0,Peripheral swelling,6,16483523
3,22.0,Alopecia,6,16483523
4,22.0,Hypoaesthesia,6,16483523
0,22.0,Pain,6,16483530
1,22.0,Memory impairment,6,16483530
0,22.0,Lip blister,3,16483537
1,22.0,Fatigue,6,16483537
2,22.0,Stress,6,16483537
3,22.0,Blood blister,3,16483537
0,22.1,Neck pain,6,16483540
1,22.1,Neoplasm progression,6,16483540
2,22.1,Pharyngeal swelling,6,16483540
3,22.1,Vomiting,6,16483540
4,22.1,Diarrhoea,6,16483540
5,22.1,Hypertension,6,16483540
6,22.1,Nausea,6,16483540
7,22.1,Death,5,16483540
0,22.0,Off label use,6,16483549
1,22.0,Product use in unapproved indication,6,16483549
0,22.0,Arthritis,6,16483564
1,22.0,Fatigue,6,16483564
0,22.0,Dehydration,3,16483583
1,22.0,Fatigue,3,16483583
0,22.0,Fatigue,6,16483729
1,22.0,Bone pain,6,16483729
2,22.0,Alopecia,6,16483729
3,22.0,Joint stiffness,6,16483729
4,22.0,Leukopenia,6,16483729
5,22.0,Neoplasm progression,6,16483729
6,22.0,Hot flush,6,16483729
7,22.0,Urinary tract infection,6,16483729
0,22.0,Hair texture abnormal,3,16483736
1,22.0,Hair colour changes,3,16483736
2,22.0,Hair disorder,3,16483736
3,22.0,Alopecia,3,16483736
4,22.0,Madarosis,3,16483736
0,22.1,Alopecia,3,16483741
1,22.1,Fatigue,3,16483741
2,22.1,Condition aggravated,3,16483741
0,22.1,Dysphonia,6,16483811
1,22.1,Decreased appetite,6,16483811
2,22.1,Gait inability,6,16483811
3,22.1,Diarrhoea,6,16483811
4,22.1,Dehydration,6,16483811
5,22.1,Hypertension,6,16483811
6,22.1,Asthenia,3,16483811
7,22.1,Vomiting,6,16483811
8,22.1,Death,5,16483811
9,22.1,Abdominal distension,6,16483811
10,22.1,Weight decreased,6,16483811
11,22.1,Taste disorder,6,16483811
12,22.1,Fatigue,6,16483811
0,22.1,Circumstance or information capable of leading to medication error,6,16483815
1,22.1,Decreased appetite,6,16483815
2,22.1,Asthenia,3,16483815
3,22.1,Hypoacusis,3,16483815
4,22.1,Nausea,6,16483815
5,22.1,Fatigue,6,16483815
0,22.1,Dyspnoea,6,16483818
1,22.1,Malaise,6,16483818
0,22.0,Fatigue,6,16483826
1,22.0,Alopecia,6,16483826
0,22.0,Erosive oesophagitis,3,16483908
1,22.0,Haematemesis,3,16483908
0,22.0,Lung abscess,6,16483919
1,22.0,Pneumonitis,6,16483919
2,22.0,Hypertension,2,16483919
0,22.0,Cardiac arrest,1,16483922
1,22.0,Contrast media allergy,,16483922
2,22.0,Coma,,16483922
3,22.0,Death,5,16483922
0,22.0,Therapy cessation,,16483983
1,22.0,Surgery,,16483983
0,22.0,Diarrhoea,,16484013
1,22.0,Pain of skin,,16484013
2,22.0,Skin disorder,,16484013
3,22.0,Nausea,,16484013
4,22.0,Rash,,16484013
0,22.0,Hypersensitivity,1,16484019
1,22.0,Dyspnoea,1,16484019
2,22.0,Flushing,1,16484019
0,22.0,Seizure,,16484211
1,22.0,Viral infection,,16484211
0,22.0,Disease progression,,16484248
0,22.0,Alveolitis,3,16484406
0,22.0,Musculoskeletal pain,2,16484603
1,22.0,Groin pain,2,16484603
0,22.0,Malignant neoplasm progression,5,16484693
0,22.0,Polyneuropathy,6,16484697
0,22.0,Malignant neoplasm progression,6,16484890
1,22.0,Hyponatraemia,1,16484890
0,22.0,Febrile neutropenia,1,16485029
0,22.0,Cholangitis,1,16485079
0,22.0,Hepatic cancer,1,16485091
0,22.0,Colorectal cancer,,16485095
0,22.1,Spinal pain,5,16485101
1,22.1,Metastases to bone,5,16485101
2,22.1,Drug interaction,6,16485101
3,22.1,Somnolence,5,16485101
4,22.1,Dizziness,5,16485101
0,22.0,Urosepsis,5,16485125
0,22.0,Tooth disorder,6,16485130
1,22.0,Gingivitis,6,16485130
0,22.0,Ejection fraction decreased,6,16485176
0,22.0,Intestinal obstruction,5,16485184
0,22.1,Spinal pain,1,16485264
1,22.1,Spinal pain,3,16485264
2,22.1,Chills,1,16485264
3,22.1,Vision blurred,1,16485264
4,22.1,Dental fistula,6,16485264
5,22.1,Dental fistula,1,16485264
6,22.1,Night sweats,6,16485264
0,22.0,Adverse event,6,16485287
1,22.0,Malignant neoplasm progression,5,16485287
0,22.1,Influenza like illness,6,16485431
1,22.1,Gastrointestinal disorder,6,16485431
2,22.1,Nausea,3,16485431
3,22.1,Ill-defined disorder,6,16485431
4,22.1,Dehydration,6,16485431
5,22.1,Pain,3,16485431
6,22.1,Renal failure,6,16485431
7,22.1,Intestinal obstruction,6,16485431
8,22.1,Blood blister,3,16485431
9,22.1,Gastrointestinal obstruction,6,16485431
10,22.1,Insomnia,3,16485431
11,22.1,Urinary tract infection,6,16485431
12,22.1,Frequent bowel movements,6,16485431
0,22.1,Gastrointestinal necrosis,5,16485441
0,22.0,Death,5,16485447
0,22.0,Intentional product use issue,6,16485462
1,22.0,Gingivitis,6,16485462
2,22.0,Tooth infection,6,16485462
0,22.0,Metastases to central nervous system,6,16485498
1,22.0,Metastases to liver,6,16485498
2,22.0,Radiation pneumonitis,6,16485498
3,22.0,Malignant pleural effusion,6,16485498
4,22.0,Malignant neoplasm progression,6,16485498
0,22.0,Skin swelling,2,16485519
1,22.0,Skin ulcer,2,16485519
2,22.0,Rash,2,16485519
0,22.0,Ileus,1,16485544
0,22.0,Sedation,6,16485601
1,22.0,Lung adenocarcinoma,6,16485601
2,22.0,Metastases to bone,6,16485601
3,22.0,Metastases to lymph nodes,6,16485601
4,22.0,Bone pain,6,16485601
5,22.0,Off label use,6,16485601
6,22.0,Metastases to spine,6,16485601
0,22.0,Dehydration,1,16485607
1,22.0,Nausea,3,16485607
2,22.0,Diarrhoea,1,16485607
3,22.0,Early satiety,6,16485607
4,22.0,Sluggishness,1,16485607
5,22.0,Dysgeusia,3,16485607
6,22.0,Vomiting,6,16485607
7,22.0,Gastroenteritis viral,1,16485607
8,22.0,Abdominal discomfort,6,16485607
9,22.0,Hypophagia,6,16485607
10,22.0,Abdominal distension,6,16485607
11,22.0,Dizziness,3,16485607
0,22.0,Alopecia,3,16485661
1,22.0,Psychological trauma,6,16485661
0,22.0,Pain,6,16485667
1,22.0,Alopecia,2,16485667
2,22.0,Emotional distress,6,16485667
3,22.0,Psychological trauma,6,16485667
4,22.0,Anxiety,6,16485667
5,22.0,Impaired quality of life,6,16485667
0,22.0,Erythema,1,16485697
0,22.0,Leukopenia,6,16485831
1,22.0,Vaginal discharge,6,16485831
2,22.0,Disease progression,6,16485831
3,22.0,Death,5,16485831
4,22.0,Anal fistula,6,16485831
5,22.0,Weight decreased,6,16485831
6,22.0,Sinus disorder,6,16485831
7,22.0,Leukocytosis,6,16485831
8,22.0,Nausea,6,16485831
9,22.0,Iron deficiency anaemia,6,16485831
10,22.0,Acute kidney injury,6,16485831
11,22.0,Normocytic anaemia,6,16485831
12,22.0,Facial wasting,6,16485831
13,22.0,Asthenia,6,16485831
14,22.0,Vaginal haemorrhage,6,16485831
15,22.0,Tumour necrosis,6,16485831
16,22.0,Decreased appetite,6,16485831
17,22.0,Escherichia urinary tract infection,1,16485831
18,22.0,Hydronephrosis,6,16485831
19,22.0,Stomal hernia,6,16485831
0,22.0,Haematochezia,1,16485838
1,22.0,Product use in unapproved indication,6,16485838
2,22.0,Gastrointestinal haemorrhage,1,16485838
0,22.0,Acute myeloid leukaemia,6,16485851
1,22.0,Pancytopenia,6,16485851
0,22.0,Hypoaesthesia,1,16485852
0,22.0,Intestinal perforation,5,16485853
0,22.0,Obstruction,1,16485870
0,22.0,Disease progression,5,16485887
0,22.0,Product adhesion issue,6,16485894
1,22.0,Treatment noncompliance,6,16485894
2,22.0,Inappropriate schedule of product administration,6,16485894
3,22.0,Application site exfoliation,6,16485894
0,22.0,Pruritus,6,16485904
1,22.0,Underdose,6,16485904
2,22.0,Rash papular,6,16485904
0,22.0,Back pain,1,16485955
1,22.0,Localised oedema,1,16485955
2,22.0,Skin infection,1,16485955
0,22.0,Drug resistance,6,16485965
1,22.0,Neoplasm progression,6,16485965
0,22.0,Palpitations,1,16486047
1,22.0,Asthenia,1,16486047
2,22.0,Hot flush,1,16486047
0,22.0,Anaphylactic reaction,1,16486048
0,22.0,Bile duct stenosis,6,16486051
0,22.0,Vomiting,1,16486086
1,22.0,Oliguria,1,16486086
2,22.0,Abdominal pain,1,16486086
3,22.0,Asthenia,1,16486086
4,22.0,Urinary tract infection,1,16486086
5,22.0,Pyrexia,1,16486086
6,22.0,Intestinal obstruction,1,16486086
7,22.0,Bacteraemia,3,16486086
8,22.0,Diarrhoea,1,16486086
9,22.0,Ascites,1,16486086
10,22.0,Hypertension,1,16486086
11,22.0,Neoplasm,1,16486086
12,22.0,Sepsis,1,16486086
13,22.0,Constipation,1,16486086
0,22.0,Thrombocytopenia,3,16486106
1,22.0,Anaemia,3,16486106
0,22.0,Acute kidney injury,2,16486211
1,22.0,Nausea,6,16486211
0,22.0,Deep vein thrombosis,6,16486327
0,22.0,Neutropenia,6,16486344
1,22.0,Pleural effusion,6,16486344
2,22.0,Pancytopenia,6,16486344
3,22.0,Ejection fraction decreased,6,16486344
4,22.0,Haematotoxicity,6,16486344
0,22.0,Malignant neoplasm progression,5,16486425
0,22.0,Constipation,2,16486431
1,22.0,Mydriasis,2,16486431
2,22.0,Musculoskeletal stiffness,2,16486431
3,22.0,Urinary retention,2,16486431
0,22.0,Death,,16486620
0,22.1,General physical health deterioration,3,16486763
1,22.1,Cell death,2,16486763
2,22.1,Back pain,3,16486763
3,22.1,Fatigue,1,16486763
4,22.1,Cough,4,16486763
5,22.1,Asthenia,3,16486763
6,22.1,Chest pain,1,16486763
7,22.1,Hypertension,1,16486763
8,22.1,Platelet count increased,1,16486763
9,22.1,Dyspnoea,1,16486763
10,22.1,Pyrexia,1,16486763
11,22.1,Neutrophil count increased,1,16486763
12,22.1,Fatigue,2,16486763
13,22.1,Diarrhoea,1,16486763
0,22.0,Fall,3,16486764
1,22.0,Injury,3,16486764
2,22.0,Malignant neoplasm progression,3,16486764
0,22.0,Death,5,16486790
1,22.0,Respiratory distress,6,16486790
0,22.0,Neutropenia,,16486890
0,22.0,Hypoaesthesia,2,16486940
1,22.0,Bone marrow failure,2,16486940
0,22.0,Thrombosis,1,16487240
0,22.0,Acute kidney injury,,16487334
1,22.0,Transaminases increased,,16487334
2,22.0,Hepatic ischaemia,,16487334
3,22.0,Hepatic function abnormal,,16487334
4,22.0,Malignant neoplasm progression,,16487334
5,22.0,Anaemia,,16487334
6,22.0,Thrombocytopenia,,16487334
7,22.0,Dehydration,,16487334
8,22.0,Lactic acidosis,,16487334
9,22.0,Thrombotic microangiopathy,,16487334
10,22.0,Acute respiratory failure,,16487334
11,22.0,Multiple organ dysfunction syndrome,,16487334
0,22.0,Dizziness,,16487335
1,22.0,Fatigue,,16487335
2,22.0,Ecchymosis,,16487335
3,22.0,Haemoglobin decreased,,16487335
4,22.0,Haemolysis,,16487335
5,22.0,Acute kidney injury,,16487335
6,22.0,Red blood cell schistocytes present,,16487335
7,22.0,Malignant neoplasm progression,,16487335
8,22.0,Rales,,16487335
9,22.0,Disease progression,,16487335
10,22.0,Pulmonary oedema,,16487335
11,22.0,Wheezing,,16487335
12,22.0,Dehydration,,16487335
13,22.0,Hypothyroidism,,16487335
14,22.0,Dyspnoea,,16487335
15,22.0,Multiple organ dysfunction syndrome,,16487335
0,22.1,Vertigo,2,16487453
1,22.1,Nausea,2,16487453
2,22.1,Rash,2,16487453
3,22.1,Headache,3,16487453
4,22.1,Somnolence,3,16487453
0,22.0,Underdose,6,16487550
1,22.0,Urinary tract infection,1,16487550
0,22.0,Death,,16487551
0,22.0,Anaemia,3,16487576
1,22.0,Haematology test abnormal,,16487576
2,22.0,Inappropriate schedule of product administration,3,16487576
0,22.0,Secondary adrenocortical insufficiency,2,16487631
1,22.0,Adrenocorticotropic hormone deficiency,2,16487631
0,22.0,Metastases to meninges,5,16487634
0,22.0,Arthralgia,,16487656
0,22.0,Febrile bone marrow aplasia,3,16487660
0,22.0,Disease progression,,16487708
0,22.0,Disease progression,,16487720
0,22.0,Confusional state,6,16487734
1,22.0,Hypotension,6,16487734
0,22.0,Neutropenia,5,16487736
1,22.0,Infection,5,16487736
2,22.0,Cardiopulmonary failure,5,16487736
3,22.0,Ileus,5,16487736
4,22.0,Diarrhoea,5,16487736
0,22.0,Ejection fraction decreased,6,16487739
0,22.0,Oxygen saturation decreased,1,16487769
1,22.0,Pruritus generalised,1,16487769
2,22.0,Vision blurred,1,16487769
3,22.0,Ocular hyperaemia,1,16487769
4,22.0,Nausea,1,16487769
5,22.0,Generalised erythema,1,16487769
6,22.0,Hypotension,1,16487769
0,22.0,Death,5,16487799
0,22.0,Hypokinesia,3,16487980
1,22.0,Confusional state,3,16487980
2,22.0,Bradyphrenia,3,16487980
3,22.0,Disorientation,3,16487980
4,22.0,Movement disorder,3,16487980
0,22.0,Death,5,16488029
0,22.0,Death,5,16488036
0,22.0,Death,5,16488041
0,22.0,Death,5,16488047
0,22.0,Hepatitis acute,2,16488124
0,22.0,Renal failure,6,16488187
1,22.0,Hypertension,6,16488187
2,22.0,Hypercholesterolaemia,6,16488187
0,22.1,Pericardial effusion,2,16488229
0,22.0,Depressed level of consciousness,1,16488675
1,22.0,Seizure,6,16488675
2,22.0,Cardio-respiratory arrest,1,16488675
3,22.0,Ventricular fibrillation,1,16488675
0,22.0,Hyponatraemia,1,16488719
1,22.0,Cardio-respiratory arrest,5,16488719
2,22.0,Immune-mediated hepatitis,1,16488719
0,22.1,Anaemia,3,16488724
1,22.1,Dizziness,6,16488724
2,22.1,Paraesthesia,6,16488724
3,22.1,Neuropathy peripheral,3,16488724
4,22.1,Condition aggravated,6,16488724
0,22.0,Death,5,16488782
0,22.0,Death,5,16488792
0,22.0,Pyrexia,1,16488811
1,22.0,Peripheral coldness,6,16488811
2,22.0,Headache,1,16488811
3,22.0,Back pain,6,16488811
4,22.0,Arthralgia,6,16488811
5,22.0,Feeling hot,6,16488811
6,22.0,Cough,1,16488811
7,22.0,Nasal congestion,1,16488811
0,22.0,Back pain,6,16488822
1,22.0,Pruritus generalised,6,16488822
0,22.0,Rash,6,16488937
0,22.0,Pruritus generalised,1,16488946
1,22.0,Pain in jaw,3,16488946
2,22.0,Hepatic enzyme increased,1,16488946
3,22.0,Disturbance in attention,3,16488946
4,22.0,Anaemia,1,16488946
5,22.0,Nausea,3,16488946
6,22.0,Fungal skin infection,3,16488946
7,22.0,Osteonecrosis of jaw,2,16488946
8,22.0,Palpitations,3,16488946
0,22.0,Cardiac failure,1,16489043
0,22.0,Malignant neoplasm progression,6,16489049
1,22.0,Invasive breast carcinoma,6,16489049
2,22.0,Metastases to lymph nodes,6,16489049
3,22.0,Metastases to bone,6,16489049
0,22.0,Death,,16489172
0,22.0,Interstitial lung disease,2,16489310
0,22.0,Erythema multiforme,6,16489316
0,22.0,Femur fracture,2,16489318
0,22.0,Liver disorder,2,16489364
1,22.0,Autoimmune hepatitis,6,16489364
0,22.0,Off label use,6,16489382
1,22.0,Death,5,16489382
2,22.0,Intentional product use issue,6,16489382
0,22.0,Gait disturbance,6,16489390
1,22.0,Musculoskeletal stiffness,6,16489390
2,22.0,Drug ineffective,6,16489390
0,22.0,Interstitial lung disease,6,16489391
0,22.0,Pain,6,16489397
1,22.0,Neoplasm progression,6,16489397
2,22.0,Hypotension,6,16489397
3,22.0,Decreased appetite,6,16489397
4,22.0,Night sweats,6,16489397
5,22.0,Tongue disorder,6,16489397
6,22.0,Weight decreased,6,16489397
7,22.0,Axillary pain,6,16489397
8,22.0,Irritability,6,16489397
9,22.0,Pruritus,6,16489397
0,22.0,Neutropenia,1,16489416
1,22.0,Colony stimulating factor therapy,6,16489416
0,22.0,Abdominal discomfort,1,16489417
1,22.0,Headache,6,16489417
2,22.0,Malaise,6,16489417
0,22.0,C-reactive protein increased,6,16489495
1,22.0,Bloch-Sulzberger syndrome,2,16489495
2,22.0,Drug hypersensitivity,2,16489495
3,22.0,Drug eruption,2,16489495
4,22.0,Skin erosion,2,16489495
5,22.0,Lichenoid keratosis,2,16489495
6,22.0,Pruritus,2,16489495
7,22.0,Skin lesion,2,16489495
8,22.0,Eczema,2,16489495
9,22.0,Erythema,2,16489495
0,22.0,Cerebral infarction,6,16489518
0,22.0,Disease progression,3,16489519
0,22.0,Laryngospasm,6,16489549
0,22.0,Neoplasm progression,6,16489561
0,22.0,Neoplasm progression,6,16489562
0,22.0,White blood cell count decreased,6,16489588
0,22.1,Blood iron decreased,6,16489632
1,22.1,Neoplasm progression,6,16489632
0,22.0,White blood cell count decreased,6,16489657
1,22.0,Neutropenia,6,16489657
0,22.0,Intentional product use issue,6,16489695
1,22.0,Death,5,16489695
0,22.0,Pneumothorax,1,16489705
1,22.0,Pneumothorax,1,16489705
0,22.0,Skin disorder,1,16489752
0,22.0,Proteinuria,6,16489806
0,22.0,Decreased appetite,3,16489896
1,22.0,Hypophagia,1,16489896
2,22.0,Diarrhoea,3,16489896
3,22.0,Stomatitis,3,16489896
0,22.0,Venoocclusive liver disease,3,16490085
0,22.0,Therapy cessation,,16490158
1,22.0,Surgery,,16490158
0,22.0,Off label use,6,16490178
1,22.0,Death,5,16490178
2,22.0,Hypervigilance,3,16490178
0,22.0,Colorectal cancer,,16490234
0,22.0,Colorectal cancer,3,16490236
0,22.0,Pyrexia,1,16490251
1,22.0,Pancytopenia,1,16490251
2,22.0,Diarrhoea,2,16490251
0,22.1,Hypertension,1,16490299
1,22.1,Dyspnoea,1,16490299
2,22.1,Hypersensitivity,1,16490299
3,22.1,Supraventricular tachycardia,1,16490299
4,22.1,Pulmonary oedema,1,16490299
5,22.1,Bronchospasm,1,16490299
0,22.0,Disease progression,,16490309
0,22.0,Surgery,,16490382
1,22.0,Therapy cessation,,16490382
0,22.0,Death,,16490414
0,22.0,Ileus,1,16490424
0,22.1,Inappropriate antidiuretic hormone secretion,1,16490449
0,22.0,Myocardial infarction,5,16490466
1,22.0,Death,5,16490466
0,22.0,Bone marrow failure,2,16490581
0,22.0,Metastases to liver,3,16490620
0,22.0,Colorectal cancer,,16490659
0,22.0,Disease complication,,16490697
1,22.0,Colostomy,,16490697
0,22.0,Thrombocytopenia,1,16490833
1,22.0,Interstitial lung disease,2,16490833
2,22.0,Pyrexia,1,16490833
0,22.0,Hot flush,,16490882
1,22.0,Fatigue,,16490882
2,22.0,Diarrhoea,,16490882
0,22.0,Therapy cessation,,16490928
1,22.0,Hospitalisation,,16490928
0,22.0,Metastases to central nervous system,6,16490949
1,22.0,Malignant neoplasm progression,6,16490949
2,22.0,Drug resistance,6,16490949
0,22.0,Malignant neoplasm progression,6,16490950
1,22.0,Drug ineffective,6,16490950
2,22.0,Drug resistance,6,16490950
0,22.0,Death,,16490953
0,22.0,Disease progression,,16491012
1,22.0,Therapy cessation,,16491012
0,22.0,Rash,,16491100
1,22.0,Stomatitis,,16491100
0,22.0,Therapy change,,16491118
1,22.0,Pancytopenia,,16491118
0,22.0,Neutropenia,,16491170
1,22.0,Therapy change,,16491170
0,22.0,Rash macular,1,16491188
0,22.0,Blood glucose increased,,16491226
1,22.0,Hot flush,,16491226
0,22.0,Rash papular,3,16491315
0,22.0,Drug interaction,6,16491336
1,22.0,Hypoglycaemia,6,16491336
2,22.0,Drug level increased,6,16491336
0,22.0,Drug resistance,6,16491340
1,22.0,Gastric ulcer,3,16491340
2,22.0,Cough,6,16491340
3,22.0,Weight decreased,6,16491340
4,22.0,Malignant neoplasm progression,6,16491340
0,22.0,Asthenia,,16491355
1,22.0,Disease progression,,16491355
2,22.0,Metastases to lung,,16491355
3,22.0,Decreased appetite,,16491355
4,22.0,Metastases to central nervous system,,16491355
0,22.0,Contusion,4,16491367
1,22.0,Cognitive disorder,6,16491367
2,22.0,Memory impairment,6,16491367
3,22.0,Fatigue,3,16491367
0,22.1,Pruritus,2,16491372
1,22.1,Cardiomyopathy,2,16491372
0,22.1,Breast cancer,5,16491388
1,22.1,Hydronephrosis,2,16491388
2,22.1,Dizziness,6,16491388
3,22.1,Cardiac arrest,5,16491388
4,22.1,Confusional state,6,16491388
5,22.1,Vomiting,6,16491388
6,22.1,Blood creatinine increased,2,16491388
7,22.1,Headache,6,16491388
8,22.1,Metastasis,5,16491388
9,22.1,Leukopenia,1,16491388
10,22.1,Malignant neoplasm progression,5,16491388
11,22.1,General physical health deterioration,6,16491388
0,22.0,Palpitations,1,16491390
1,22.0,Eczema,1,16491390
2,22.0,Visual impairment,6,16491390
3,22.0,Asthenia,6,16491390
4,22.0,Nausea,6,16491390
5,22.0,Leukopenia,1,16491390
6,22.0,Decreased appetite,6,16491390
7,22.0,Paraesthesia,6,16491390
8,22.0,Nasopharyngitis,1,16491390
9,22.0,Epistaxis,6,16491390
10,22.0,Insomnia,6,16491390
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16491424
1,22.0,Mucosal inflammation,2,16491424
2,22.0,Hypokalaemia,6,16491424
3,22.0,Dehydration,6,16491424
4,22.0,Neutropenia,6,16491424
5,22.0,Failure to thrive,6,16491424
0,22.0,Intervertebral disc protrusion,6,16491440
0,22.0,EGFR gene mutation,6,16491487
1,22.0,Malignant neoplasm progression,2,16491487
2,22.0,Cerebral infarction,6,16491487
3,22.0,Drug resistance,6,16491487
0,22.0,Neutropenia,1,16491515
0,22.0,Hospice care,,16491545
0,22.0,Disease progression,,16491555
1,22.0,Therapy change,,16491555
0,22.0,Device connection issue,,16491591
1,22.0,Enterocutaneous fistula,,16491591
2,22.0,Pleural effusion,,16491591
3,22.0,Fistula of small intestine,,16491591
4,22.0,Small intestinal perforation,,16491591
0,22.0,Therapeutic product effect incomplete,6,16491616
1,22.0,Prostatic specific antigen increased,6,16491616
2,22.0,Malignant hypertension,4,16491616
3,22.0,Malignant neoplasm progression,3,16491616
0,22.0,Abdominal pain,3,16491738
1,22.0,Hydronephrosis,1,16491738
2,22.0,Abdominal discomfort,3,16491738
3,22.0,Haemoglobin decreased,6,16491738
4,22.0,Haematocrit decreased,6,16491738
5,22.0,Fatigue,3,16491738
6,22.0,Laziness,3,16491738
7,22.0,Ovarian cancer,6,16491738
8,22.0,Nausea,3,16491738
9,22.0,Hypertension,1,16491738
10,22.0,Malaise,6,16491738
0,22.1,Hypothyroidism,3,16491747
1,22.1,Haemoptysis,1,16491747
2,22.1,C-reactive protein increased,6,16491747
3,22.1,Bone marrow failure,2,16491747
4,22.1,Gastrooesophageal reflux disease,1,16491747
5,22.1,Pyrexia,1,16491747
6,22.1,Peripheral sensory neuropathy,3,16491747
7,22.1,Pyrexia,2,16491747
8,22.1,Constipation,1,16491747
0,22.0,Malignant neoplasm progression,6,16491751
1,22.0,Drug resistance,6,16491751
0,22.0,Ophthalmoplegia,3,16491829
0,22.0,Sudden death,5,16491878
0,22.0,Pleural effusion,6,16491955
1,22.0,Performance status decreased,3,16491955
2,22.0,Haematotoxicity,1,16491955
3,22.0,Sepsis,6,16491955
4,22.0,Loss of personal independence in daily activities,2,16491955
5,22.0,Neutropenia,6,16491955
0,22.0,Embolism venous,1,16492017
1,22.0,Pulmonary embolism,1,16492017
0,22.0,International normalised ratio increased,6,16492113
1,22.0,Atrial fibrillation,3,16492113
2,22.0,Blister,6,16492113
3,22.0,Dyspnoea,6,16492113
0,22.0,Hypertension,6,16492267
1,22.0,Neuropathy peripheral,6,16492267
2,22.0,Malaise,6,16492267
0,22.0,Neuropathy peripheral,6,16492272
1,22.0,Alopecia,6,16492272
2,22.0,Taste disorder,6,16492272
3,22.0,Hypertension,6,16492272
0,22.0,Febrile neutropenia,6,16492337
0,22.1,Infusion site pain,1,16492618
1,22.1,Erythema,1,16492618
2,22.1,Feeling hot,1,16492618
3,22.1,Infusion site urticaria,1,16492618
4,22.1,Urticaria,1,16492618
5,22.1,Pruritus,1,16492618
6,22.1,Swelling face,1,16492618
7,22.1,Flushing,1,16492618
8,22.1,Periorbital oedema,1,16492618
9,22.1,Infusion site erythema,1,16492618
0,22.0,Death,5,16492634
0,22.0,Pancreatitis,2,16492651
0,22.0,Lymphocyte count decreased,6,16492667
1,22.0,Breast pain,2,16492667
2,22.0,Effusion,3,16492667
3,22.0,Fatigue,6,16492667
4,22.0,Anaemia,2,16492667
0,22.0,Death,5,16492674
0,22.0,Death,5,16492676
0,22.0,Asthenia,6,16492721
1,22.0,Weight decreased,6,16492721
2,22.0,Pollakiuria,6,16492721
0,22.1,Syncope,1,16492814
0,22.0,Epilepsy,6,16492840
0,22.0,Hypotension,5,16492841
1,22.0,Nervous system disorder,3,16492841
2,22.0,Oxygen saturation decreased,6,16492841
3,22.0,Behaviour disorder,3,16492841
4,22.0,Hyporeflexia,6,16492841
5,22.0,Drug ineffective,5,16492841
6,22.0,Neurological decompensation,5,16492841
7,22.0,Product use in unapproved indication,6,16492841
8,22.0,Areflexia,6,16492841
9,22.0,General physical health deterioration,6,16492841
10,22.0,Bulbar palsy,6,16492841
11,22.0,Death,5,16492841
12,22.0,Dyspnoea,3,16492841
13,22.0,Bradycardia,5,16492841
14,22.0,Muscular weakness,5,16492841
15,22.0,Hemiparesis,3,16492841
16,22.0,Guillain-Barre syndrome,6,16492841
17,22.0,Paraesthesia,3,16492841
0,22.0,Product use in unapproved indication,6,16492848
1,22.0,Hypokalaemia,2,16492848
0,22.0,Maternal exposure before pregnancy,6,16492920
1,22.0,Abortion spontaneous,6,16492920
0,22.0,Palpitations,3,16492935
1,22.0,Diarrhoea,3,16492935
2,22.0,Therapeutic product effect decreased,6,16492935
0,22.0,Death,5,16492952
0,22.0,Death,5,16493124
0,22.0,Hypoacusis,6,16493186
1,22.0,Dysgeusia,2,16493186
2,22.0,Insomnia,6,16493186
3,22.0,Ear congestion,3,16493186
4,22.0,Fatigue,3,16493186
5,22.0,Gastroenteritis viral,2,16493186
6,22.0,Accidental overdose,6,16493186
7,22.0,Muscle spasms,2,16493186
8,22.0,Somnolence,3,16493186
9,22.0,Fatigue,6,16493186
10,22.0,Middle ear effusion,3,16493186
11,22.0,Hypersensitivity,2,16493186
12,22.0,Nasopharyngitis,2,16493186
13,22.0,Ear swelling,2,16493186
0,22.0,Chest discomfort,1,16493208
1,22.0,Palpitations,1,16493208
2,22.0,Tachycardia,1,16493208
0,22.0,Balance disorder,6,16493210
1,22.0,Pelvic pain,6,16493210
2,22.0,Granulocytosis,6,16493210
3,22.0,Vertigo,6,16493210
4,22.0,Disorientation,6,16493210
5,22.0,Peripheral sensory neuropathy,6,16493210
6,22.0,Hemiparesis,6,16493210
7,22.0,Leukocytosis,6,16493210
8,22.0,Blood creatinine increased,6,16493210
9,22.0,Headache,6,16493210
0,22.0,Procedural complication,3,16493302
0,22.0,Adverse event,6,16493306
0,22.0,Ischaemic stroke,1,16493308
0,22.0,Neuropathy peripheral,6,16493334
1,22.0,Bone marrow toxicity,6,16493334
2,22.0,Off label use,6,16493334
3,22.0,Product use issue,6,16493334
0,22.0,Renal impairment,6,16493362
1,22.0,Ileus paralytic,1,16493362
2,22.0,Neutropenia,6,16493362
3,22.0,Liver injury,6,16493362
4,22.0,Bone marrow failure,6,16493362
0,22.0,Neuropathy peripheral,6,16493383
1,22.0,Ascites,6,16493383
2,22.0,Condition aggravated,6,16493383
3,22.0,Deep vein thrombosis,6,16493383
0,22.0,Osteoporosis,6,16493504
0,22.0,Erythema,1,16493536
1,22.0,Hypotension,1,16493536
2,22.0,Tachycardia,1,16493536
3,22.0,Anaphylactic reaction,1,16493536
4,22.0,Hypersensitivity,1,16493536
5,22.0,Bronchospasm,1,16493536
0,22.1,Anaemia,1,16493553
1,22.1,Dizziness,3,16493553
2,22.1,Fatigue,3,16493553
3,22.1,Pain,1,16493553
4,22.1,Humerus fracture,1,16493553
5,22.1,Alopecia,3,16493553
0,22.0,Death,5,16493562
1,22.0,Intentional product use issue,6,16493562
0,22.0,Constipation,2,16493636
1,22.0,Asthenia,2,16493636
2,22.0,Decreased appetite,3,16493636
3,22.0,Fungal infection,3,16493636
4,22.0,Diarrhoea,3,16493636
0,22.0,Toothache,6,16493638
1,22.0,Tooth loss,6,16493638
2,22.0,Osteonecrosis of jaw,3,16493638
3,22.0,Oral infection,6,16493638
4,22.0,Off label use,6,16493638
0,22.0,Renal disorder,6,16493644
0,22.0,Death,5,16493654
0,22.0,Cardiac disorder,6,16493665
0,22.1,Malaise,6,16493711
1,22.1,Blood count abnormal,6,16493711
0,22.0,Fibula fracture,2,16493735
1,22.0,Foot fracture,2,16493735
2,22.0,Tibia fracture,2,16493735
0,22.0,White blood cell count decreased,6,16493738
0,22.0,Intentional product use issue,6,16493786
0,22.0,Agranulocytosis,1,16493872
0,22.0,Pain,3,16493961
1,22.0,Arthralgia,3,16493961
2,22.0,Asthenia,6,16493961
3,22.0,Weight decreased,6,16493961
4,22.0,Hepatic neoplasm,3,16493961
5,22.0,Pruritus,1,16493961
0,22.0,Encephalopathy,6,16494001
0,22.0,Death,5,16494030
1,22.0,Drug resistance,3,16494030
2,22.0,Malignant neoplasm progression,6,16494030
3,22.0,Ageusia,3,16494030
0,22.1,Back pain,2,16494043
1,22.1,Aortitis,2,16494043
0,22.0,Psychological trauma,6,16494183
1,22.0,Alopecia,3,16494183
0,22.0,Psychological trauma,6,16494232
1,22.0,Alopecia,2,16494232
2,22.0,Anxiety,6,16494232
3,22.0,Pain,6,16494232
4,22.0,Emotional distress,6,16494232
5,22.0,Impaired quality of life,6,16494232
0,22.0,Cholecystitis,1,16494236
0,22.0,Alopecia,2,16494246
1,22.0,Psychological trauma,6,16494246
0,22.0,Alopecia,2,16494249
0,22.0,Psychological trauma,6,16494273
1,22.0,Alopecia,2,16494273
0,22.0,Psychological trauma,6,16494278
1,22.0,Alopecia,2,16494278
0,22.0,Hypertransaminasaemia,2,16494279
0,22.0,Immune-mediated adverse reaction,1,16494329
1,22.0,Neurological symptom,1,16494329
2,22.0,Liver disorder,1,16494329
0,22.0,Arrhythmia,4,16494345
0,22.0,Alopecia,2,16494469
1,22.0,Psychological trauma,6,16494469
0,22.0,Fall,6,16494511
1,22.0,Insomnia,6,16494511
2,22.0,Feeling abnormal,6,16494511
3,22.0,Wound,6,16494511
4,22.0,Adverse event,6,16494511
0,22.1,Haematuria,1,16494702
1,22.1,Pleural effusion,1,16494702
2,22.1,Pneumonia,5,16494702
0,22.0,Age-related macular degeneration,6,16494815
0,22.0,Enterocolitis,1,16494840
0,22.0,Death,5,16494894
0,22.0,Chills,1,16494898
1,22.0,Back pain,1,16494898
2,22.0,Musculoskeletal pain,1,16494898
0,22.0,Death,5,16494907
0,22.0,Sinusitis,6,16494908
1,22.0,Hot flush,6,16494908
0,22.0,Abdominal discomfort,2,16494935
1,22.0,Asthenia,6,16494935
2,22.0,Constipation,1,16494935
3,22.0,Blood pressure increased,3,16494935
4,22.0,Rhinorrhoea,6,16494935
5,22.0,Fatigue,3,16494935
6,22.0,Abdominal distension,6,16494935
7,22.0,Computerised tomogram abnormal,6,16494935
8,22.0,Carbohydrate antigen 125 increased,6,16494935
9,22.0,Retching,6,16494935
10,22.0,Nausea,2,16494935
11,22.0,Disease progression,6,16494935
12,22.0,Small intestinal obstruction,3,16494935
13,22.0,Headache,3,16494935
14,22.0,Abdominal pain,3,16494935
15,22.0,Drug ineffective,6,16494935
0,22.0,Death,5,16494954
0,22.1,Product dose omission,6,16494970
1,22.1,Blister,2,16494970
2,22.1,Blood pressure increased,6,16494970
3,22.1,Gingival pain,2,16494970
4,22.1,Gingival bleeding,1,16494970
0,22.0,Cerebral infarction,5,16495035
